Validity and Reliability of the Turkish St. Marks Incontinence Score

March 21, 2023 updated by: Yasemin Ecem Temel Pekmez, Atlas University
For the Turkish validity and reliability study of St.Mark's (Vaizey) Incontinence Score, which consists of 7 questions, it will be applied to 65 people diagnosed with anal incontinence after it is translated by translation-retranslation method.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

65

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Istanbul, Turkey
        • Acibadem Atakent University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients over the age of 18 who were diagnosed with anal incontinence in our clinic will be included in the study. Persons who have difficulties in understanding and writing Turkish will be excluded from the study. Patients will fill out the St. Mark's Incontinence Score.

Description

Inclusion Criteria:

  • people with the complatint of anal incontinence
  • being volunteered to participate

Exclusion Criteria:

- having difficulties in understanding and speaking Turkish

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Turkish Validation and Reliability of St. Mark's Incontinence Score
Time Frame: 1 month
St. Mark's Incontinence Score which shows the disease severity of anal incontinence patients and is used in the follow-up of their recovery status. The Turkish validity and reliability study of Mark's incontinence score will be conducted and it will be translated into Turkish.
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Atlas University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 7, 2023

Primary Completion (Actual)

March 8, 2023

Study Completion (Actual)

March 10, 2023

Study Registration Dates

First Submitted

February 23, 2023

First Submitted That Met QC Criteria

March 3, 2023

First Posted (Actual)

March 6, 2023

Study Record Updates

Last Update Posted (Actual)

March 23, 2023

Last Update Submitted That Met QC Criteria

March 21, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • YETPekmez

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pelvic Floor Disorders

Clinical Trials on Anal incontinence patients with St. Mark's Incontinence Score

  • The Functional Gut Clinic
    Recruiting
    Pelvipower for Faecal Incontinence
    Faecal Incontinence
    United Kingdom
  • Novartis Pharmaceuticals
    Terminated
    Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors
    Melanoma | Advanced EGFR Mutant Non Small Cell LungCancer (NSCLC) | KRAS G12-mutant NSCLC | Esophageal Squamous Cell Cancer (SCC) | Head/Neck SCC | Advanced Gastrointestinal Stromal Tumors (GIST) | Advanced NRAS/BRAFT wt Cutaneous Melanoma
    United States, Taiwan, Netherlands, Canada, Spain, Singapore, Italy, Japan, South Korea

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Senegal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe